Deerfield Special Situations Fund, L.P.'s Net Worth

$486 Million

Estimate Recalculated Feb 23, 2024 04:05PM EST

Who is Deerfield Special Situations Fund, L.P.?

Deerfield Special Situations Fund, L.P. has an estimated net worth of $486 Million. This is based on reported shares across multiple companies, which include RHYTHM PHARMACEUTICALS, INC., Dicerna Pharmaceuticals Inc, Invuity, Inc., DYNAVAX TECHNOLOGIES CORP, XERIS PHARMACEUTICALS INC, Invitae Corp, Auspex Pharmaceuticals, Inc., Fibrocell Science, Inc., TriVascular Technologies, Inc., CONSTELLATION PHARMACEUTICALS INC, NeurogesX Inc, Kiniksa Pharmaceuticals, Ltd., RIGEL PHARMACEUTICALS INC, eHealth, Inc., Nivalis Therapeutics, Inc., Shockwave Medical, Inc., Aclaris Therapeutics, Inc., Vanda Pharmaceuticals Inc., ANTARES PHARMA, INC., AERIE PHARMACEUTICALS INC, AVADEL PHARMACEUTICALS PLC, Axogen, Inc., ARVINAS INC., Neos Therapeutics, Inc., Loxo Oncology, Inc., NeuroMetrix, Inc., Avalanche Biotechnologies, Inc., Mirum Pharmaceuticals, Inc., ZAFGEN, INC., Cyclacel Pharmaceuticals, Inc., Syros Pharmaceuticals, Inc., Recro Pharma, Inc., CATALYST BIOSCIENCES, INC., CytomX Therapeutics, Inc., CAS MEDICAL SYSTEMS INC, PROTEON THERAPEUTICS INC, AveXis, Inc., SteadyMed Ltd., Cabaletta Bio, Inc., aTYR PHARMA INC, ALIMERA SCIENCES INC, STREAMLINE HEALTH SOLUTIONS INC., Frequency Therapeutics, Inc., Audentes Therapeutics, Inc., Talon Therapeutics, Inc., NxStage Medical, Inc., HI TECH PHARMACAL CO INC, DUSA PHARMACEUTICALS INC, PAR PHARMACEUTICAL COMPANIES, INC., ANADYS PHARMACEUTICALS INC, XENOPORT INC, ISTA PHARMACEUTICALS INC, Somaxon Pharmaceuticals, Inc., NITROMED INC, VIA Pharmaceuticals, Inc., EMAGEON INC, THIRD WAVE TECHNOLOGIES INC /WI, and INSPIRE PHARMACEUTICALS INC.

SEC CIK

Deerfield Special Situations Fund, L.P.'s CIK is 0001354395

Past Insider Trading and Trends

2006 was Deerfield Special Situations Fund, L.P.'s most active year for acquiring shares with 124 total transactions. Deerfield Special Situations Fund, L.P.'s most active month to acquire stocks was the month of June. 2011 was Deerfield Special Situations Fund, L.P.'s most active year for disposing of shares, totalling 162 transactions. Deerfield Special Situations Fund, L.P.'s most active month to dispose stocks was the month of May. 2009 saw Deerfield Special Situations Fund, L.P. paying a total of $40,247,286.68 for 46,758,133 shares, this is the most they've acquired in one year. In 2007 Deerfield Special Situations Fund, L.P. cashed out on 1,885,903 shares for a total of $24,724,365.01, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

RHYTHM PHARMACEUTICALS, INC. (RYTM) Snapshot price: $47.9

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
937.01K
$17.00
937.01K
Oct 10
Form 3
0
0
No matching records found

Dicerna Pharmaceuticals Inc No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-15.36%
-321.96K
$11.36
-$3,657,513.62
1.77M
Nov 21 - Nov 25
Form 4
-100.00%
-214.16K
$9.05
-$1,938,354.00
0
Nov 7
Form 4
-4.27%
-117.78K
$11.40
-$1,279,557.02
2.64M
Oct 10 - Oct 15
Form 4
+100.00%
2.43M
$15.00
$15,000,000.00
4.86M
Feb 4
Form 3
0
0
No matching records found

Invuity, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-9.85%
-184.80K
$6.22
-$1,148,909.05
1.69M
Dec 12 - Dec 14
Form 3
0
0
No matching records found

DYNAVAX TECHNOLOGIES CORP (DVAX) Snapshot price: $12.96

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-4.85M
$0.25
-$1,213,992.59
0
Oct 22
Form 4
0
0
Dec 27
Form 4
0
0
Oct 18
Form 4/A
0
0
Jul 18
Form 4
0
0
Jul 18
Form 4
+24.35%
950K
$4.40
$4,180,000.00
4.85M
Oct 4
Form 4/A
+7.92%
24.1K
$5.50
$132,542.77
328.45K
May 15
Form 4
+8.68%
102.74K
$5.36
$563,171.22
1.29M
May 11 - May 15
Form 4
+1.86%
69.2K
$5.61
$384,670.40
3.8M
Apr 28 - May 1
Form 4/A
+0.71%
25.28K
$6.02
$152,068.00
3.59M
Apr 5
Form 4
+3.96%
142.09K
$5.50
$781,795.92
3.73M
Apr 20 - Apr 24
Form 4
+3.53%
122.48K
$6.03
$738,516.68
3.59M
Apr 3 - Apr 5
Form 4
+3.61%
120.61K
$5.97
$720,008.39
3.47M
Mar 15 - Mar 17
Form 4
+0.99%
32.8K
$6.02
$197,234.51
3.34M
Mar 7 - Mar 9
Form 4
+3.73%
119.23K
$5.90
$703,600.07
3.31M
Mar 3
Form 3/A
0
0
No matching records found

XERIS PHARMACEUTICALS INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-0.84%
-7.24K
$15.09
-$109,250.53
856.47K
Feb 8 - Feb 11
Form 4
-1.69%
-14.81K
$15.02
-$222,442.86
863.71K
Feb 5 - Feb 7
Form 4
-0.79%
-7.04K
$15.12
-$106,448.09
878.52K
Jan 28 - Jan 29
Form 4
-11.44%
-114.44K
$15.43
-$1,766,192.63
885.56K
Jan 23 - Jan 25
Form 4
2.5M
$15.00
2.5M
Jun 25
Form 3
0
0
No matching records found